Elevations in estrogen (17b-estradiol, E2) are associated with increased alcohol drinking by women and experimentally in rodents. E2 alters the activity of the dopamine system, including the ventral tegmental area (VTA) and its projection targets, which plays an important role in binge drinking. A previous study demonstrated that during high E2 states, VTA dopamine neurons in female mice are more sensitive to ethanol excitation. However, the mechanisms responsible for the ability of E2 to enhance ethanol sensitivity of VTA dopamine neurons have not been investigated. In this study, we used selective agonists and antagonists to examine the role of estrogen receptor subtypes (ERa and ERb) in regulating the ethanol sensitivity of VTA dopamine neurons and found that ERa promotes the enhanced ethanol response of VTA dopamine neurons. We also demonstrated that the E2-induced increase in ethanol excitation requires the activity of the metabotropic glutamate receptor, mGluR1, which is known to couple with ERa at the plasma membrane. To investigate the behavioral relevance of these findings, we administered lentivirus expressing short hairpin RNAs targeting either ERa or ERb into the VTA and found that knockdown of each receptor in the VTA reduced binge-like ethanol drinking in female, but not male, mice. Reducing ERa in the VTA had a more dramatic effect on binge-like drinking than reducing ERb, consistent with the ability of ERa to alter ethanol sensitivity of dopamine neurons. These results provide important insight into sex-specific mechanisms that drive excessive alcohol drinking.
Introduction
Binge drinking is defined by the National Institute on Alcohol Abuse and Alcoholism as consuming enough alcohol within a 2-hour period to reach a blood ethanol concentration (BEC) of at least 0.08%. Binge drinking accounts for more than half of the deaths and three-quarters of the economic costs associated with excessive drinking (Stahre et al., 2014; Sacks et al., 2015) .
Women are more susceptible than men to the devastating health effects associated with alcohol abuse, including liver disease, cardiomyopathy, brain damage, and heightened risk for breast cancer (Agabio et al., 2016; White et al., 2017; Szabo, 2018) . Women who binge drink also report having more physically and mentally poor days compared with male binge drinkers (Wen et al., 2012) . Unfortunately, more women are drinking excessively now compared with previous decades (Grant et al., 2017) . The biological factors that contribute to binge drinking by women are not well understood, although ovarian hormones, specifically estrogen (17b-estradiol, E2), may play a role. Circulating E2 levels in women are positively associated with alcohol consumption (Muti et al., 1998; Martin et al., 1999; Martel et al., 2017) , and numerous alcohol drinking studies in female rodents have demonstrated that E2 administration increases alcohol drinking (Ford et al., 2002a; Marinelli et al., 2003; Reid et al., 2003; Ford et al., 2004; Quirarte et al., 2007; Rajasingh et al., 2007; Satta et al., 2018a) . Understanding the molecular and cellular mechanisms of action of E2 in enhancing ethanol drinking is important for developing new approaches to reduce excessive drinking by women.
The mesocorticolimbic dopamine (DA) system is critical for the rewarding and reinforcing effects of ethanol (Gonzales et al., 2004; Lovinger and Alvarez, 2017) . E2 has potent modulatory effects on this system (Yoest et al., 2018a) . For example, E2 enhances cocaine-, amphetamine-, and potassium-stimulated DA release in the striatum of rats and mice (Becker, 1990a, b; Thompson and Moss, 1994; Tobiansky et al., 2016; Yoest et al., 2018b) , and potentiates ethanol-stimulated DA release in the prefrontal cortex of female rats (Dazzi et al., 2007) . In accord with this finding, ethanol-induced excitation of ventral tegmental area (VTA) DA neurons in female mice is augmented when E2 levels are elevated (Vandegrift et al., 2017) .
However, the specific estrogen receptor(s) that mediate the enhancement of ethanol-stimulated firing of VTA DA neurons is currently not known.
The first goal of this study was to determine whether estrogen receptor a (ERa) or estrogen receptor b (ERb) is responsible for the effect of E2 on the response of VTA DA neurons to ethanol. We used selective agonists and antagonists to ERa and ERb combined with extracellular recordings of VTA DA neurons. Because membrane-bound estrogen receptors can rapidly activate cell signaling pathways through interactions with metabotropic glutamate receptors (mGluRs) and affect neurotransmission and behavior (Tonn Eisinger et al., 2018) , the second goal of this study was to determine if the enhancement of ethanol-stimulated VTA DA neuron firing by E2 is dependent on mGluR1 activity.
The third goal of this study was to examine the potential relevance of estrogen receptors expressed in the VTA on alcohol drinking. We used virus-expressed short hairpin (sh)RNAs to reduce the expression of ERa or ERb in the mouse VTA and measured binge ethanol drinking.
Together, the results from our behavioral and electrophysiological experiments indicate that ERα activation in the VTA enhances both ethanol-stimulated firing of VTA DA neurons and binge drinking in female mice. These studies provide important mechanistic and behavioral insights into estrogen receptor signaling in the brain that are relevant to AUD in females.
Materials and Methods

Animals
Female C57BL/6J mice were purchased from the Jackson Laboratory (Bar Harbor, ME, USA) at the age of 8 weeks and used for immunohistochemistry, electrophysiology, and behavioral experiments at the age of 10-14 weeks. Transgenic mice containing a bacterial artificial chromosome (BAC) expressing EGFP under the control of the Esr2 promoter were obtained from the Mutant Mouse Regional Resource Center at the University of California, Davis (strain B6.FVB(Cg)-Tg(Esr2-EGFP)ID169Gsat/TmilMmucd, stock 036904-UCD) (Milner et al., 2010) and were used as a reporter for ERβ expression in immunohistochemistry experiments due to a lack of commercially available antibodies specific for mouse ERb (Snyder et al., 2010) . Mice were housed in groups of 3-5 in a temperature-and humidity-controlled room with a 12-hour light/dark cycle (lights on at 6 am), with food and water available ad libitum, except water was not available during the limited-access ethanol drinking tests described below.
Animal care adhered to the National Institutes of Health Guide for the Care and Use of Laboratory Animals, and all procedures were approved by the UIC Animal Care Committee.
Vaginal cytology
The estrous cycles of gonadally-intact female mice were assessed by vaginal cytology for at least two weeks prior to performing experiments, as previously described (Vandegrift et al., 2017) . Briefly, a cotton swab was moistened with sterile water and gently rotated at the vaginal opening. The swab was wiped on a microscope slide, and the smear was immediately analyzed by bright field microscopy using an EVOS® FL inverted microscope (Thermo Fisher Scientific).
Estrus was identified by a large quantity of cornified epithelial cells, while diestrus was determined by a predominance of leukocytes (Nelson et al., 1982) . These two phases differ in circulating E2 levels. Serum E2 levels in mouse are higher during late diestrus (diestrus II) than estrus and are not statistically significantly different from levels during proestrus as measured by gas chromatography-tandem mass spectrometry (Nilsson et al., 2015) .
Fluorescent immunohistochemistry (IHC)
Mice were euthanized using a lethal dose of a commercial euthanasia solution containing pentobarbital (Somnasol) and transcardially perfused with ice-cold phosphate buffered saline (PBS), followed by 4% paraformaldehyde (PFA). Brains were removed and post-fixed in PFA overnight and cryoprotected in 30% sucrose. Serial coronal sections (40 µm-thick) were collected through the VTA. Sections were blocked in 5% normal donkey serum (Jackson Immunoresearch, #017-000-121, RRID: AB_2337258) and then incubated with various combinations of the following primary antibodies: ERa, rabbit polyclonal, Millipore Sigma, #06-935, RRID: AB_310305; GFP, mouse monoclonal 3E6, Thermo Scientific, #A-11120, RRID: AB_221568; tyrosine hydroxylase (TH), mouse monoclonal LNC1, Millipore Sigma, #MAB318, RRID: AB_827536; TH, rabbit polyclonal, Millipore Sigma, #AB152, RRID:
AB_390204. Secondary antibodies were Alexa Fluor 594-conjugated donkey anti-rabbit (Jackson Immunoresearch, #711-585-152, RRID: AB_2340621) and Alexa Fluor 488-conjugated donkey anti-mouse (Jackson Immunoresearch, #715-545-150, RRID: AB_2340846). Sections were mounted onto slides with Vectashield® mounting medium (Vector Laboratories). Images in Fig. 1 were acquired with a Zeiss LSM 710 laser scanning confocal microscope using a 40X objective (all mice were in estrus). Images from Fig. 6 were acquired using an EVOS FL microscope (Thermo Fisher) using a 4X objective.
Ovariectomy (OVX)
Mice were anesthetized with intraperitoneal (IP) injections of ketamine (100 mg/kg) and xylazine (8 mg/kg). Hair on the dorsal flanks was trimmed using a hair trimmer, and the skin was disinfected using 70% isopropanol wipes. Bilateral incisions were made in the skin, and a small hole was teased in the muscle wall to allow access to the abdomen. The ovaries and associated fat pads were dissected away from the uterine horns. The muscle wall was sutured, and the skin was closed with wound clips. Mice received a subcutaneous (SC) injection of 2 mg/kg meloxicam immediately after surgery and once on the following day for analgesia.
Cessation of the estrous cycle was verified by obtaining vaginal smears for a few days after OVX. Mice recovered for 2 weeks prior to beginning drug treatments.
In vivo drug treatments
Diarylpropionitrile (DPN, selective ERb agonist, Tocris Bioscience), 4,4',4''-(4-Propyl-
[1H]-pyrazole-1,3,5-triyl)trisphenol (PPT, selective ERa agonist, Tocris Bioscience), and 17bestradiol-3-benzoate, herein referred to as E2 (MilliporeSigma) were prepared in solutions of 90% sesame oil/10% ethanol (VEH). DPN and PPT were prepared to final concentrations of 0.5 mg/ml. Mice were injected subcutaneously (SC) with ~1 mg/kg in a 50 µl volume (final ethanol dose from vehicle solution was < 0.2 g/kg). Mice were treated once per day for three days, with the final dose given 1 h prior to euthanasia. For E2 treatment, 0.2 µg E2 in 50 µl volume (~10 µg/kg) was injected SC on the first 2 days and 1 µg of E2 in 50 µl volume (~50 µg/kg) on the third day, 1 h prior to euthanasia. These doses and timing of E2 treatment were chosen because they result in E2 plasma levels similar to proestrus (Vandegrift et al., 2017) , when E2 levels 9 peak. The concentrations of PPT and DPN were chosen to balance receptor selectivity with occupancy (Sepehr et al., 2012; Hilderbrand and Lasek, 2018) .
Extracellular recordings and in vitro drug treatments
VTA-containing brain slices were prepared for electrophysiology as previously described (Brodie et al., 1999; Dutton et al., 2017) . DA VTA neurons were identified both anatomically and based on electrophysiological characteristics that have been well established in the literature and in the Brodie lab (Brodie et al., 1999) . Spontaneous spike frequency (firing rate) was recorded and changes in firing rate were determined. A calibrated infusion pump was used to apply ethanol and the mGluR1 antagonist JNJ 16259685 to the aCSF from stock solutions prepared at 100-1000X the final concentration. JNJ 16259685 was prepared in 100% DMSO and the final concentration in the bath was 0.2 µM. The ERb antagonist PHTPP (4-[2-Phenyl-5,7bis(trifluoromethyl)pyrazolo [1,5-a] pyrimidin-3-yl]phenol, Tocris Bioscience) and ERa antagonist MPP (1,3-Bis(4-hydroxyphenyl)-4-methyl-5-[4-(2-piperidinylethoxy)phenol]-1Hpyrazole dihydrochloride, Tocris Bioscience) were administered via the micropipette by adding the drug to the microelectrode filling solution. Drugs were added to the 0.9% NaCl microelectrode filling solution and time was permitted for the antagonists to diffuse from the recording pipette into the extracellular space around the neuron being recorded.
Lentiviral vectors
Lentiviruses expressing short hairpin RNAs (shRNAs) targeting Esr1 (shEsr1-1785, GGCATGGAGCATCTCTACA), Esr2 (shEsr2-1089, GTACGAAGACAGAGAAGTG), or a sequence not predicted to target any gene in the mouse genome (shScr) were generated from the pLL3.7 vector (Lasek et al., 2007) . The Esr1-targeting sequence was obtained from Musatov et al (Musatov et al., 2006) , who demonstrated an 80% reduction in ERa protein and transcript in vitro and complete lack of ERa protein in the hypothalamus after adeno-associated virus injection. We previously validated the shEsr1 lentiviral construct used in this study in vitro in Satta et al (Satta et al., 2018b) and observed a 70% knockdown of Esr1 transcript. The lentiviral construct expressing shEsr2 was tested for the ability to knockdown Esr2 in Neuro-2a cells and reduced Esr2 transcript levels by 94.3 ± 1.5%. We were unable to validate the shEsr2 construct in vivo because transcript levels in the VTA are below the limit of detection by qPCR (Cq values ~34) and because there are no commercially available antibodies specific to mouse ERb (Snyder et al., 2010) . The pLL3.7 vector included a cytomegalovirus (CMV)-enhanced green fluorescent protein (EGFP) reporter cassette for infection site verification after the completion of behavioral testing. Lentiviral plasmids are available from Addgene (#120720 and #120722).
Stereotaxic injection of lentivirus into the VTA
Gonadally intact, 8-to 12-week-old female C57BL/6J mice were anesthetized with a solution of ketamine and xylazine and placed in a digital stereotaxic alignment apparatus. After bregma alignment and skull leveling, 0.28 mm diameter holes were drilled bilaterally (A/P: -3.2, M/L: ±0.5) for lentivirus microinjection. Lentivirus was delivered to the VTA (D/V: -4.7) at a rate of 0.2 µl/min for a total injection volume of 1 µl/hemisphere. After surgery, mice were maintained on a normal 12-hour light/dark cycle for 1 week. Mice were then transferred to a reversed light/dark cycle room (lights off at 10 am and on at 10 pm) and housed individually for two weeks to acclimate to the change in light/dark cycle before testing drinking.
Ethanol and sucrose drinking tests
The drinking in the dark (DID) procedure was employed as a model of binge ethanol consumption because it allows mice to achieve blood ethanol levels exceeding 80 mg/dl in a 2-4 h period (Rhodes et al., 2007; Dutton et al., 2017) , which is defined as binge drinking by the National Institute on Alcohol Abuse and Alcoholism. For ethanol drinking, mice were given access to a single bottle of 20% ethanol, 3 hours into the dark cycle for 2 h per day on Tuesday-Thursday and 4 h on Friday. Ethanol intake was measured on Friday at 2 and 4 h into the session.
Blood was collected from the tail vein immediately after the 4 h session on Friday and blood ethanol concentrations (BECs) were measured using a nicotinamide adenine dinucleotide-alcohol dehydrogenase (NAD-ADH) enzymatic assay (Zapata et al., 2006) . Two independent cohorts of mice were injected with lentiviruses and tested for ethanol drinking and data were combined from both cohorts after excluding inaccurate or absent viral infections (shScr, n=10; shEsr1, n=10; shEsr2, n=9). For sucrose drinking, animals were presented with a solution of 2% sucrose in water instead of ethanol using the same DID procedure as described for ethanol. Two independent cohorts of mice were injected with lentiviruses and tested for sucrose drinking and data combined from both cohorts (shScr, n=11; shEsr1, n=10; shEsr2, n=8) . Viral infection in the VTA was confirmed for both cohorts, except the in the 2 nd shScr (n=5) control group because of an error in tissue processing. However, the two shScr cohorts did not differ statistically in sucrose intake and so the 2 nd cohort was included in the data analysis.
Statistical analysis
Data are presented as the mean ± SEM. Statistical comparisons were made using Student's t-test, one-way ANOVA, two-way ANOVA or two-way repeated measures (RM) ANOVA as indicated for each experiment in the results section. Holm-Sidak's or Tukey's multiple comparisons tests were performed as indicated (Prism, Graphpad Software, Inc., La Jolla, CA). A p value of < 0.05 was considered significant.
Results
ERα and ERβ are expressed in DA neurons and non-DA cells in the mouse VTA
The estrogen receptors, ERa and ERb, have been detected in the VTA of mice and rats (Kritzer, 1997; Shughrue et al., 1997; Shughrue and Merchenthaler, 2001; Creutz and Kritzer, 2002; Mitra et al., 2003; Kritzer and Creutz, 2008; Milner et al., 2010) . In rats, ERa and ERb immunoreactivity are observed in DA neurons and non-DA cells in the VTA as demonstrated by dual-labeling with an antibody to TH, an enzyme in the DA biosynthetic pathway (Creutz and Kritzer, 2002; Kritzer and Creutz, 2008) , but to our knowledge, this has not been investigated in mice. To confirm that ERa and ERb are present in DA neurons in the mouse VTA, we performed fluorescent IHC on VTA sections of gonadally intact female mice. Transgenic mice expressing EGFP from the Esr2 promoter (the gene encoding ERb) were used as a reporter for ERb expression and the GFP signal was amplified with an antibody to GFP. We first examined GFP and ERa localization and observed both ERa and GFP immunoreactivity in the VTA ( Fig.   1A -C). Nearly all of the cells expressing GFP were positive for ERa, but there were many cells that were positive for ERa that did not express GFP. These results suggest that ERa and ERb are co-expressed in some cells in the VTA, but that ERa is expressed more widely than ERb in the VTA. GFP was visible in TH-positive and TH-negative cells, indicating that ERb is expressed in both DA and non-DA cells in the mouse VTA ( Fig. 1G-I 
Activation of ERα enhances ethanol sensitivity of VTA DA neurons
We previously demonstrated that OVX mice treated with E2 exhibit enhanced ethanolinduced excitation of VTA DA neurons (Vandegrift et al., 2017) . In order to determine which estrogen receptor is involved in enhancing ethanol sensitivity, we measured ethanol-induced excitation (40-120 mM) of VTA DA neurons from OVX mice treated with PPT (an ERαselective agonist), DPN (an ERβ-selective agonist), or VEH. VTA neurons from OVX mice treated with PPT had significantly higher ethanol-induced excitation compared with neurons from DPN-and VEH-treated mice. (Fig. 2, n=10 -11 per group, two-way RM ANOVA, ethanol concentration: F(2,56) =57.02, p<0.0001; treatment: F(2,28) = 4.05, p=0.028; concentration x treatment interaction: F(4,56) =3.06, p= 0.024). In response to bath application of 80 mM ethanol, the firing rate of neurons from PPT-treated mice increased by 18.5 ± 1.97%. In comparison, the firing rate of neurons from DPN-and VEH-treated mice increased by 7.7 ± 1.8% and 11.1 ± 2.8%, respectively. Post-hoc Holm-Sidak's multiple comparisons test demonstrated a significant increase in ethanol-induced excitation in response to 80 mM ethanol from mice treated with PPT compared with VEH (p=0.046) and DPN (p=0.0044), and in response to 120 mM ethanol from mice treated with PPT compared with VEH (p=0.038) and DPN (p=0.0082). These results indicate that activation of ERα enhances the response of VTA DA neurons to ethanol in OVX mice and suggests that the E2-induced increase in ethanol sensitivity is likely due to activation of ERα.
ERα regulates ethanol sensitivity of VTA DA neurons from mice in diestrus
VTA DA neurons from mice in diestrus are more sensitive to ethanol excitation when compared with neurons from mice in estrus (Vandegrift et al., 2017) . This enhancement of ethanol-induced excitation in diestrus is blocked by acute administration of the ERa/ERb antagonist, ICI 182,780, directly to the VTA slice (Vandegrift et al., 2017) . To determine if this effect results from blocking the activity of a specific estrogen receptor, we administered MPP, an ERα-selective antagonist, or PHTPP, an ERβ-selective antagonist, to VTA slices from mice in diestrus or estrus using the recording pipette. The response to 80 mM ethanol was tested prior to administration of the antagonist and again 70-80 minutes later, after the antagonist diffused from the recording pipette onto the cell of interest. The ERa antagonist MPP decreased the excitatory response of VTA DA neurons to ethanol from mice in diestrus, but had no effect on neurons from mice in estrus ( Fig. 3A -C, n = 5-6 per group, two-way RM ANOVA, time: F(1,9)= 7.46, p = 0.023; phase: F(1,9) = 3.50, p = 0.094; time x phase interaction: F(1,9) = 10.50, p = 0.01). Post-hoc Holm-Sidak's multiple comparisons test demonstrated a significant difference in ethanol-induced excitation between estrus (9.9 ± 1.4% increase) and diestrus (15.9 ± 0.8% increase) prior to MPP treatment (p=0.0054), consistent with our previous findings (Vandegrift et al., 2017) . After administration of MPP, there was no longer a difference (p=0.60) in ethanol-induced excitation between diestrus (9.6 ± 1.3% increase) and estrus (10.5 ± 1.1% increase) because of a significant reduction in ethanol-induced excitation in neurons from mice in diestrus (p=0.0058). These results suggest that ERα acutely regulates ethanol sensitivity in the VTA in an estrous cycle phase-dependent manner.
In contrast to results obtained with the ERa antagonist, the ERb antagonist PHTPP had no effect on ethanol sensitivity of VTA DA neurons. As expected, there was a significant main effect of estrous cycle phase, indicating enhanced ethanol excitation in neurons from mice in diestrus compared with estrus ( Fig. 3D-F , n = 5-6 per group, two-way RM ANOVA, time: F(1,9)= 0.18, p=0.68; phase: F(1,9)=7.17, p=0.025; time x phase interaction: F(1,9) = 0.088, p=0.77).
Neurons from mice in estrus exhibited no increase in the response to ethanol, as ethanol increased firing by 8.0 ± 1.2% and 7.9 ± 1% before and after PHTPP delivery, respectively.
Likewise, while neurons from mice in diestrus initially responded to 80 mM ethanol with an 18.1 ± 3.3% increase in firing rate, after PHTPP delivery, these neurons responded similarly to ethanol with a 17.4 ± 4.5% increase in firing rate. Together, these results indicate that ERα, but not ERβ, enhances the ethanol-induced excitation of VTA DA neurons in female mice during diestrus, when E2 levels are higher than in estrus. mGluR1 is required for the E2-induced enhancement of ethanol excitation E2 rapidly activates membrane-bound estrogen receptors that couple to mGluRs in hippocampal (Huang and Woolley, 2012) and striatal (Grove-Strawser et al., 2010) neurons. We hypothesized that mGluR activation might be occurring in the VTA of mice after E2 treatment and thus contributing to the enhancement of ethanol-simulated firing. To test this, OVX mice were administered E2 or VEH and the response to 40-120 mM ethanol was measured in VTA DA neurons before and after bath application of the mGluR1 antagonist, JNJ 16259685. JNJ 16259685 did not affect ethanol excitation of VTA DA neurons from OVX mice treated with VEH ( Fig.4A-B , n = 5 per group, two-way RM ANOVA, treatment: F (1, 4) = 0.52, p=0.51; ethanol concentration: F(2,8) = 21.47, p=0.0006; treatment x concentration interaction: F(2,8) = 1.39, p = 0.30). In contrast, JNJ 16259685 decreased the response of VTA DA neurons to ethanol in OVX mice treated with E2 ( Fig. 4C-D , n = 6 per group, two-way RM ANOVA, treatment: F(1,5) = 111.58, p = 0.019; ethanol concentration: F(2,10) = 30.44, p<0.0001; treatment x concentration interaction: F(2,10) =1. 56, p=0.26) . Neurons from E2-treated OVX mice initially responded to 80 mM ethanol with a 17.8 ± 2.7% increase in firing rate. After 45 minutes of JNJ 16259685 exposure, the neurons responded to ethanol with a 9.9 ± 3.1% increase in firing rate.
These results indicate that E2-mediated enhancement of excitation by ethanol depends on mGluR1 activation.
mGluR1 regulates ethanol sensitivity of VTA DA neurons from mice during diestrus
We tested whether the increased ethanol sensitivity we observed during diestrus compared with estrus could be attributed to activation of mGluR. We measured the response to 40-120 mM ethanol in VTA DA neurons from mice in diestrus and estrus before and after bath application of JNJ 16259685. Ethanol excitation of VTA DA neurons from females in estrus did not change after treatment with JNJ 16259685 ( Figure 5A -B, n = 5 per group, two-way RM ANOVA, treatment: F(1,4) = 0.18, p=0.70; ethanol concentration: F(2,8) = 60.66, p < 0.0001; treatment x concentration interaction: F(2,8) =1.51, p= 0.28). For example, neurons from mice in estrus exhibited a 10.4 ± 1.6% increase in firing in response to 80 mM ethanol before treatment with the mGluR1 antagonist and an 8.9 ± 1.7% increase after treatment. In contrast, treatment with JNJ 16259685 decreased ethanol excitation of VTA DA neurons from females in diestrus ( Fig. 5C -D, n = 6 per group, two-way RM ANOVA, treatment: F(1,5) =7.44, p=0.041; ethanol concentration: F(2,10) = 6.56, p=0.015; treatment x concentration interaction: F(2,10) =2. 46, p=0.14) . Neurons from mice in diestrus responded to 80 mM ethanol with a 14.9 ± 1.6% increase in firing rate before treatment with the mGluR1 antagonist and a 7.9 ± 3.1%. increase in firing rate after treatment. These results indicate that mGluR1 activity is required for the increased sensitivity of VTA DA neurons to ethanol from mice in diestrus, similar to what we observed in mice treated with E2.
Intra-VTA knockdown of estrogen receptors reduces binge ethanol consumption in female mice
Female mice drink more alcohol than male mice in a binge drinking test, an effect that is attributed to E2 (Satta et al., 2018a) . Our results demonstrating that ERa activation increases the sensitivity of VTA DA neurons to ethanol suggest that ERa expression in the VTA might regulate binge drinking because of the critical role of the VTA in this behavior. To determine if estrogen receptors in the VTA are important for alcohol drinking, we used shRNAs to locally knockdown expression of Esr1 (encoding ERa) or Esr2 (encoding ERb) in the VTA of gonadally intact female mice. Mice were injected with lentiviral vectors expressing shEsr1, shEsr2, or a shScr control and tested for binge ethanol drinking using the drinking in the dark test 3 weeks after injection. Two-way RM ANOVA revealed significant main effects of shRNA and time on ethanol intake during the 2-hour drinking sessions, but no treatment x time interaction ( Fig. 6A, shRNA: F(2,26) = 13.10, p < 0.0001; time: F(3,78) = 6.02, p = 0.001; interaction: F(6,78) = 0.61, p = 0.72). Post-hoc testing to identify differences in shRNA groups demonstrated that reducing Esr1 expression in the VTA resulted in a 30% decrease (p < 0.0001) in 2-hour ethanol intake over the 4 days. Reducing Esr2 expression in the VTA also resulted a significant, albeit less pronounced, 16% decrease (p = 0.038) in 2-hour ethanol intake over the 4 days. Ethanol intake during the 4-hour session on day 4 was attenuated by a reduction in estrogen receptor levels in the VTA (Fig. 6B , F (2, 26) = 6.85, p = 0.0041). Multiple comparisons testing revealed a significant 29% decrease in ethanol drinking in mice expressing shEsr1 (p = 0.0030) and a nonsignificant 17% decrease in mice expressing shEsr2 (p = 0.097) in the VTA during the 4-hour session. Consistent with reduced ethanol intake during the 4-hour session, BECs were lower in mice with estrogen receptor knockdown in the VTA (Fig. 6C , one-way ANOVA, F(2, 25) = 3.35, p = 0.051). This effect was driven by a 55% reduction in BECs in the shEsr1 treatment group (p = 0.041), as BECs in the shEsr2 group were not significantly different from the shScr group (24% reduction, p = 0.51). We also tested water intake one day prior to measuring ethanol consumption in the same mice and did not observe an effect of estrogen receptor knockdown on water intake during a 2-hour period (Fig. 6D) , indicating that reducing estrogen receptors in the VTA does not affect general fluid intake. Viral infection in the VTA was confirmed by dual immunofluorescent staining of brain sections using antibodies to TH and GFP (Fig. 6G-J) .
Selective knockdown of estrogen receptors in the VTA did not affect estrous cycles (data not shown), as mice continued to cycle normally throughout the duration of the experiment. Binge ethanol drinking also did not significantly vary during the estrous cycle, as reported previously (Satta et al., 2018a) , nor was drinking altered only at specific phases of the estrous cycle by knockdown of estrogen receptors (data not shown). These results indicate that reducing levels of estrogen receptors in the VTA of female mice decreases binge-like drinking, with a stronger effect of ERa knockdown.
In order to determine if the effects of intra-VTA estrogen receptor knockdown on bingelike drinking were specific to ethanol or might extend to other rewarding substances, we performed the 4-day drinking in the dark test using 2% sucrose (instead of ethanol) with mice expressing shEsr1, shEsr2, or shScr in the VTA. There were no significant effects of shRNA, time, or an shRNA x time interaction for sucrose drinking during the 2-hour sessions or during the final 4-hour session (Fig. 6E-F) , demonstrating that knockdown of estrogen receptors in the VTA of female mice does not affect consumption of all rewarding substances. Finally, to determine if the effect of estrogen receptor knockdown in the VTA is sex-specific, we injected lentiviruses expressing shScr, shEsr1, or shEsr2 into the VTA of male mice and tested them in the ethanol drinking in the dark test. Despite the fact that estrogen receptors are expressed in the VTA of males, knockdown of Esr1 or Esr2 did not alter ethanol drinking in male mice ( Fig. 6-1 ).
Fluorescent immunostaining with antibodies to GFP and ERa demonstrated a 54% reduction in
ERa levels in shEsr1virus-infected cells. These results suggest a sexually dimorphic role for estrogen receptors in the VTA in ethanol binge drinking.
Discussion
The primary novel findings of this study are that: 1) activation of ERa potentiates ethanol-induced excitation of VTA DA neurons, and 2) ERa, and to a lesser extent ERb, in the 20 VTA regulates binge-like ethanol drinking. We previously demonstrated that VTA DA neurons from mice in diestrus and E2-treated OVX mice are more sensitive to ethanol excitation than neurons from mice in estrus and VEH-treated OVX mice (Vandegrift et al., 2017) . Multiple studies have found that E2-treated females consume more ethanol under various access conditions, including those that promote binge drinking (Ford et al., 2002a; Marinelli et al., 2003; Reid et al., 2003; Ford et al., 2004; Quirarte et al., 2007; Rajasingh et al., 2007; Satta et al., 2018a) . Prior to this study, it was not known which estrogen receptor(s) are responsible for these behavioral and neurophysiological effects.
Evidence that ERa is responsible for the increased sensitivity of VTA DA neurons to ethanol in females is provided by our experiments in OVX mice treated with the selective ERa agonist, PPT, and in brain slices from mice in diestrus treated with the ERa antagonist, MPP.
PPT treatment of OVX mice mimicked the effect of E2 treatment, indicating that activation of ERa is most likely the mechanism by which E2 increased ethanol excitation of VTA DA neurons. We confirmed a role for ERa in the enhanced sensitivity to ethanol in gonadally-intact mice in diestrus, showing that acute application of MPP decreased ethanol induced excitation when E2 levels are rising (Nilsson et al., 2015) . This result demonstrates that ERa is important for the enhanced response to ethanol in a natural hormonal state, and not just in gonadectomized mice treated with E2. In contrast to the results obtained with ERa, pharmacological manipulation of ERb did not alter the potency of ethanol on VTA DA neurons, even though ERb is expressed in these cells. Together, these data demonstrate an important role for E2 acting on ERa to increase ethanol sensitivity of VTA DA neurons. Although we showed that ERa is expressed in both DA and non-DA cells in the VTA, the ERa-mediated enhancement of ethanol sensitivity could conceivably be due to ERa expression on neuronal terminals in the VTA, such as those from the medial preoptic area that project to the VTA and that are known to regulate DA release in the nucleus accumbens (Tobiansky et al., 2016; McHenry et al., 2017) . Further investigation is needed to identify the specific cell types in which ERa regulates responses to ethanol in the VTA.
Our results suggest that activation of ERa would increase ethanol-stimulated DA release in target regions such as the nucleus accumbens, which might contribute to enhanced rewarding and reinforcing effects of ethanol during high-estrogen states. Dazzi et al demonstrated that ethanol increased DA release in the prefrontal cortex of OVX rats treated with E2, but not in untreated OVX rats (Dazzi et al., 2007) , and that treatment with the selective estrogen receptor modulator clomifene prevented the ethanol-induced DA elevation. It remains to be determined whether treatment with an ERa-selective agonist or antagonist would alter ethanol-induced elevation of DA in regions such as the nucleus accumbens and prefrontal cortex.
It is important to point out that basal firing rates of VTA DA neurons from mice in estrus were slightly higher than neurons from mice in diestrus. Other groups have shown that basal firing rate and bursting of VTA neurons are greater in estrus compared with diestrus (Zhang et al., 2008; Calipari et al., 2017) . Supporting this observation, DA levels in the prefrontal cortex and striatum of rats are also higher in estrus compared with diestrus (Xiao and Becker, 1994; Dazzi et al., 2007) . Of note, acute treatment of VTA slices with estrogen receptor antagonists did not decrease basal firing rates of VTA DA neurons. We also did not observe a difference in baseline firing rates in OVX mice treated with E2 compared with VEH. It is possible that the slightly higher firing rate observed in estrus compared with diestrus is not due to ongoing estrogen receptor activity, but instead might result from actions of progesterone or progesteronederived neurosteroids (Maguire et al., 2005) .
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The potential signaling mechanism(s) by which ERa increased the ethanol sensitivity of VTA DA neurons was provided by our experiments using an mGluR1 antagonist, which decreased ethanol stimulation of neurons from mice in diestrus and of neurons from OVX mice treated with E2. These results indicate that mGluR1 is required for E2-mediated enhancement of ethanol-induced excitation of VTA DA neurons and suggests that the effects of E2 may be due to rapid signaling at the cell membrane. Estrogen receptors (both ERa and ERb) functionally couple to mGluRs in various brain regions such as the hippocampus, striatum, and hypothalamus (Dewing et al., 2007; Grove-Strawser et al., 2010; Huang and Woolley, 2012; Oberlander and Woolley, 2016) . ERa and mGluRs are associated in complexes at the cell membrane with caveolin proteins (Razandi et al., 2002; Boulware et al., 2007; Dewing et al., 2007; Meitzen et al., 2013; Tabatadze et al., 2015; Pastore et al., 2019) . Our results support the possibility that a similar coupling of ERa and mGluR1 occurs in the VTA of females and that this interaction is an important regulator of the sensitivity of DA neurons to ethanol excitation. Dissecting the signaling mechanisms downstream of the ERa/mGluR1 interaction involved in ethanol sensitivity will be an important area for future research. For example, in the hippocampus, E2 acts through mGluR1 to increase the production of the endocannabinoid anandamide, which functions in a retrograde manner to activate presynaptic cannabinoid (CB1) receptors, resulting in a suppression of presynaptic GABA release (Huang and Woolley, 2012) .
This mechanism could conceivably increase the sensitivity of VTA DA neurons to ethanol.
Activation of ERa/mGluR1 by E2 in the hippocampus increases phosphorylation of ERK, which is important for the enhancement of memory by E2 .
Estrogen receptors in the VTA of female mice are important for promoting binge-like alcohol drinking, as demonstrated by shRNA-mediated knockdown of ERa and ERb. We found a stronger decrease in ethanol drinking by reducing levels of ERa compared with ERb. It is possible that this is because ERa, and not ERb, enhances excitation of VTA DA neurons by ethanol. We observed greater expression of ERa vs. ERb in the VTA, and it is also possible that the increased abundance of ERa is responsible for its more prominent role in alcohol drinking.
Reducing levels of ERb in the VTA modestly decreased binge-like ethanol drinking by females.
Although ERb does not alter the excitatory effect of ethanol on VTA DA neurons, it may play a role in the VTA in alcohol drinking through its actions on other neuronal types or by affecting the innate physiology of VTA DA neurons independently of ethanol stimulation, for instance by altering the expression of various receptors or ion channels, or by altering the physiology of non-DA neurons that indirectly affect DA VTA neurons. Future experiments will examine how ERb acts to alter neuronal activity in the VTA.
One might have predicted from our electrophysiology results that: 1) ethanol consumption during diestrus would be higher than in estrus because of the greater response to ethanol during this phase, and 2) knockdown of ERa in the VTA would only decrease ethanol drinking during diestrus, because the ERa antagonist MPP only altered ethanol-induced excitation of VTA DA neurons in diestrus and not in estrus. A close examination of our data indicated that there was no effect of estrous cycle phase on alcohol consumption, consistent with our previous findings and those of others (Roberts et al., 1998; Ford et al., 2002b; Priddy et al., 2017; Satta et al., 2018a) . Knockdown of ERa in the VTA also did not decrease drinking only 
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Interestingly, knockdown of estrogen receptors in the VTA of male mice did not affect binge-like ethanol drinking, despite the fact that males express ERa and ERb in the VTA. Sex differences in the responses to E2 are not unprecedented. For example, E2 suppresses inhibitory neurotransmission in the hippocampus in females, but not in males, and this effect is mediated by ERa that are coupled to mGluR1 (Huang and Woolley, 2012) and the ability of E2 to increase the interaction of ERa and mGluR1 in females but not in males (Tabatadze et al., 2015) . Given our results demonstrating that E2 enhancement of ethanol excitation of VTA DA neurons is mediated by a potential ERa/mGluR1 interaction, the same mechanism may be operative in the sex-specific role of estrogen receptors in the VTA on ethanol drinking. A more complete understanding of the E2-dependent signaling mechanism(s) in the VTA that drive binge ethanol drinking is an important area for future research and may lead to more effective treatments to reduce excessive drinking by women. injected with lentivirus expressing shScr (n=11), shEsr1 (n=10), or shEsr2 (n=8) and tested for 38 consumption of 2% sucrose using the same procedure as was used for ethanol drinking. Shown is sucrose intake in ml/kg over 2 h on each day of drinking. F, Sucrose intake in ml/kg during the final 4 h session. G, Illustration of a coronal brain section showing injection site in the VTA (shaded magenta). For reference, hippocampal structures are colored in yellow and the cingulum is shaded grey. H-J, Representative images of infection in the VTA of mice injected with lentivirus expressing shScr (H), shEsr1 (I), or shEsr2 (J). GFP is in green and TH is in magenta.
Figure Legends
Scalebar, 1 mm. Abbreviations, RN, red nucleus; Aq, aqueduct; SNR, substantia nigra pars reticulata; ml, medial lemniscus. 
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